Comparative Analysis of the Safety and Efficacy of Transcatheter Arterial Chemoembolization and Yttrium-90 Radioembolization in Patients with Unresectable Hepatocellular Carcinoma
Authors:
- Gordon McLennanGMGordon McLennan
- Nancy ObuchowskiNONancy Obuchowski
- Grace CheahGCGrace Cheah
- Abraham LevitinALAbraham Levitin
- Mark SandsMSMark Sands
- James SpainJSJames Spain
- Shyam SrinivasSSShyam Srinivas
- Sankaran ShrikanthanSSSankaran Shrikanthan
- Federico N. AucejoFAFederico N. Aucejo
- Richard KimRKRichard Kim
- K.V. Narayanan MenonKMK.V. Narayanan Menon
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 22 (12) , 1697-1705
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaGastroenterology, 2011
- Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)Journal of Surgical Oncology, 2010
- Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinomaCancer, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Growth Rate of Locally Recurrent Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization: Comparing the Growth Rate of Locally Recurrent Tumor with That of Primary Hepatocellular CarcinomaDigestive Diseases and Sciences, 2007
- Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameterAlimentary Pharmacology & Therapeutics, 2005
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Chemoembolization of Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001